API & INTERMEDIATES OF L-CARNITINE /INTERMEDIATES OF VENCLEXTA
Product Description
Jiangsu Bioscene Pharmaceutical Co.,Ltd
-
CN
-
2024On CPHI since
-
1Certificates
-
50 - 99Employees
Company types
Primary activities
Categories
Jiangsu Bioscene Pharmaceutical Co.,Ltd
-
CN
-
2024On CPHI since
-
1Certificates
-
50 - 99Employees
Company types
Primary activities
More Products from Jiangsu Bioscene Pharmaceutical Co.,Ltd (2)
-
Product INTERMEDIATES OF FINERENONE SIVELESTAT SODIUM
INTERMEDIATES OF FINERENONEAPI & INTERMEDIATES OF SIVELESTAT SODIUM -
Product NEW CRYSTAL FORM OF RESMETIROM
√Better chemical and mechanical stability than form I in
Rezdiffra
√Bioequivalence consistency with Rezdiffra
√Lower hygroscopicity than form I in Rezdiffra, et al.
Jiangsu Bioscene Pharmaceutical Co.,Ltd resources (1)
-
Brochure Product Schedule
We're focused on R&D and production of API and pharm-intermediates. The products which protected by valid patents are for labs R&D purposes only and are not offered for sales in countries where the sales of such products constitutes a patent infringement。
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance